“Drug developers recognize the importance of participant demographic representation in the development of safe and effective medical treatments,” said Ken Getz, professor and deputy director of the Tufts Center for […]
As the clinical trial industry staggers through an epic pandemic called COVID-19, there’s been precious little time to think about planning for 2021 and beyond. However, with some states now […]
If it’s possible to take a “this too shall pass” attitude toward the current health crisis, one has to assume that many of the clinical trials having nothing to do […]
Although, to date, most children and pregnant women have shown no special vulnerabilities to the SARS-CoV-2 virus, serious efforts should be made to “level the field” of knowledge about how […]
From waiters and waitresses serving food to patrons while wearing masks to the prospect of baseball games played without fans in the stands, it’s no understatement to say COVID-19 will […]